N/A
Manufactured by Amneal Pharmaceuticals NY LLC
14,926 FDA adverse event reports analyzed
Last updated: 2026-04-14
AMPHETAMINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Amneal Pharmaceuticals NY LLC. The most commonly reported adverse reactions for AMPHETAMINE include TOXICITY TO VARIOUS AGENTS, DRUG ABUSE, COMPLETED SUICIDE, OVERDOSE, CARDIAC ARREST. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AMPHETAMINE.
Out of 7,885 classified reports for AMPHETAMINE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 14,926 FDA FAERS reports that mention AMPHETAMINE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include TOXICITY TO VARIOUS AGENTS, DRUG ABUSE, COMPLETED SUICIDE, OVERDOSE, CARDIAC ARREST, DEATH. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Amneal Pharmaceuticals NY LLC in connection with AMPHETAMINE. Always verify the specific product and NDC with your pharmacist.